Jon Vialoux IDEXX Laboratories IDXX-Q DON'T BUY Dec 04, 2019

Jan.6-April 27 is seasonality. Healthcare stocks have made huge gains, but not IDXX. It's rolling over now and resisting its 200-day moving average. He's concerned. It's underperforming.

Jon Vialoux

Unknown

Unlock Rating

$251.860

Stock price when the opinion was issued

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY

These lab stocks are news-driven and could drop on a negative headline. Each time it pulled back, it bounced back higher. The chart looks good here and he would buy.

HOLD

They offer healthcare to animals and pets. Stay with it. He believes in how they serve pets.

WEAK BUY

Makes diagnostic equipment for veterinarians. It has sold off hard, because pet plays are seen as Covid stocks, but has been recovering (reported a beat in early August), but shares have been cold since that report.

DON'T BUY

They're too inconsistent.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jon Vialoux IDEXX Laboratories IDXX-Q DON'T BUY Dec 04, 2019

You might be interested:

IDEXX Laboratories(IDXX-Q)

IDEXX Laboratories(IDXX-Q)

IDEXX Laboratories(IDXX-Q)

IDEXX Laboratories(IDXX-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Michael Sprung

Larry Berman CFA, CMT, CTA

Stockchase Insights

Jim Cramer - Mad Money

Greg Newman